Order Article Reprints

Sabarwal A, Chakraborty S, Mahanta S, Banerjee S, Balan M, Pal S. A Novel Combination Treatment with Honokiol and Rapamycin Effectively Restricts c-Met-Induced Growth of Renal Cancer Cells, and also Inhibits the Expression of Tumor Cell PD-L1 Involved in Immune Escape. Cancers. 2020; 12(7):1782. https://doi.org/10.3390/cancers12071782

Sabarwal, Akash, Samik Chakraborty, Simran Mahanta, Selina Banerjee, Murugabaskar Balan, and Soumitro Pal. 2020. "A Novel Combination Treatment with Honokiol and Rapamycin Effectively Restricts c-Met-Induced Growth of Renal Cancer Cells, and also Inhibits the Expression of Tumor Cell PD-L1 Involved in Immune Escape" Cancers 12, no. 7: 1782. https://doi.org/10.3390/cancers12071782

Sabarwal, A., Chakraborty, S., Mahanta, S., Banerjee, S., Balan, M., & Pal, S. (2020). A Novel Combination Treatment with Honokiol and Rapamycin Effectively Restricts c-Met-Induced Growth of Renal Cancer Cells, and also Inhibits the Expression of Tumor Cell PD-L1 Involved in Immune Escape. Cancers, 12(7), 1782. https://doi.org/10.3390/cancers12071782